Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
RESEARCH TOOLSreports
Holding RBOT?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-2.69Last Year’s EPS
-2.1Same Quarter Last Year
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 03, 2022
|% Change Since: 42.28%
|Next Earnings Date:Nov 08, 2021
Earnings Call Sentiment|Neutral
The earnings call was largely focused on the positive strides made in reducing operational costs, advancing the single-port platform, and maintaining a strong financial position. However, significant challenges remain, including the need to achieve regulatory approval and address ongoing net losses.Company Guidance
During Vicarious Surgical's Q3 2024 earnings call, the company provided detailed guidance on its upcoming milestones and financial outlook. The executives highlighted their plan to integrate and validate the Version 1.0 System of their single-port robotic surgical platform by the end of the year. They aim to treat the first clinical patient in less than a year, focusing initially on ventral hernia repair, with plans to expand to other indications such as inguinal hernia repair and gynecological procedures. The pivotal clinical trial is expected to enroll 30 to 60 subjects outside the United States, following recent successful FDA precedents. Financially, the company reported a 17% reduction in operating expenses year-over-year, with a total operating expense of $17.8 million for Q3 2024. They closed the quarter with $61 million in cash and equivalents, maintaining a projected full-year cash burn of approximately $50 million and extending their cash runway into 2026.Reduced Operating Expenses
Total operating expenses fell 17% year-over-year to $17.8 million, indicating effective cost reduction initiatives.
Progress Towards Single-Port Platform
Meaningful progress was made towards the V1.0 System of the single-port platform, with integration expected by year-end, setting the stage for a pivotal clinical trial.
Strong Cash Position
Closed the third quarter with $61 million in cash, supporting projected full-year cash burn of $50 million and maintaining runway into 2026.
---
RBOT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RBOT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $11.14 | $9.15 | -17.86% |
| Aug 12, 2024 | $5.50 | $5.21 | -5.27% |
| Apr 29, 2024 | $8.40 | $8.42 | +0.24% |
| Mar 04, 2024 | $10.80 | $10.61 | -1.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Vicarious Surgical (RBOT) report earnings?
Vicarious Surgical (RBOT) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Vicarious Surgical (RBOT) earnings time?
Vicarious Surgical (RBOT) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RBOT EPS forecast?
RBOT EPS forecast for the fiscal quarter 2024 (Q4) is -2.69.
---